FI20040674A0 - Menetelmä tromboembolisten sairauksien estoon - Google Patents
Menetelmä tromboembolisten sairauksien estoonInfo
- Publication number
- FI20040674A0 FI20040674A0 FI20040674A FI20040674A FI20040674A0 FI 20040674 A0 FI20040674 A0 FI 20040674A0 FI 20040674 A FI20040674 A FI 20040674A FI 20040674 A FI20040674 A FI 20040674A FI 20040674 A0 FI20040674 A0 FI 20040674A0
- Authority
- FI
- Finland
- Prior art keywords
- thromboembolic diseases
- inhibiting
- inhibiting thromboembolic
- diseases
- thromboembolic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20040674A FI20040674A0 (fi) | 2004-05-12 | 2004-05-12 | Menetelmä tromboembolisten sairauksien estoon |
TW094113669A TWI366463B (en) | 2004-05-12 | 2005-04-28 | A method for the prevention of thrombotic, embolic and/or hemorrhagic disorders |
ARP050101922A AR050903A1 (es) | 2004-05-12 | 2005-05-11 | Metodo para la prevencion de trastornos tromboticos, embolicos y/o hemorragicos |
CN2005800142213A CN1980673B (zh) | 2004-05-12 | 2005-05-12 | 预防血栓栓塞性疾病的方法 |
KR1020067023504A KR20080020930A (ko) | 2004-05-12 | 2005-05-12 | 혈전색전증 증후군들의 예방방법 |
NZ550814A NZ550814A (en) | 2004-05-12 | 2005-05-12 | A method for the prevention of thromboembolic disorders |
EA200602096A EA010890B1 (ru) | 2004-05-12 | 2005-05-12 | Способ предотвращения тромбоэмболических расстройств |
US11/596,064 US8017609B2 (en) | 2004-05-12 | 2005-05-12 | Method for the prevention of thromboembolic disorders |
AU2005239847A AU2005239847B2 (en) | 2004-05-12 | 2005-05-12 | A method for the prevention of thromboembolic disorders |
CA002564033A CA2564033A1 (en) | 2004-05-12 | 2005-05-12 | A method for the prevention of thromboembolic disorders |
NZ579537A NZ579537A (en) | 2004-05-12 | 2005-05-12 | A method for the prevention of thromboembolic disorders |
JP2007512237A JP5074923B2 (ja) | 2004-05-12 | 2005-05-12 | 血栓塞栓性疾患の予防方法 |
EP05739367A EP1744752A2 (en) | 2004-05-12 | 2005-05-12 | A method for the prevention of thromboembolic disorders |
NZ579536A NZ579536A (en) | 2004-05-12 | 2005-05-12 | A method for the prevention of thromboembolic disorders |
PCT/FI2005/000220 WO2005107757A2 (en) | 2004-05-12 | 2005-05-12 | A method for the prevention of thromboembolic disorders |
ZA200609304A ZA200609304B (en) | 2004-05-12 | 2006-11-08 | A method for the prevention of thromboembolic disorders |
NO20065669A NO20065669L (no) | 2004-05-12 | 2006-12-08 | Fremgangsmate til a forhindre tromboemboliske lidelser. |
HK07112472.5A HK1107000A1 (en) | 2004-05-12 | 2007-11-15 | A method for the prevention of thromboembolic disorders |
US13/207,537 US8329693B2 (en) | 2004-05-12 | 2011-08-11 | Method for the prevention of thromboembolic disorders |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20040674A FI20040674A0 (fi) | 2004-05-12 | 2004-05-12 | Menetelmä tromboembolisten sairauksien estoon |
Publications (1)
Publication Number | Publication Date |
---|---|
FI20040674A0 true FI20040674A0 (fi) | 2004-05-12 |
Family
ID=32338383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20040674A FI20040674A0 (fi) | 2004-05-12 | 2004-05-12 | Menetelmä tromboembolisten sairauksien estoon |
Country Status (16)
Country | Link |
---|---|
US (2) | US8017609B2 (es) |
EP (1) | EP1744752A2 (es) |
JP (1) | JP5074923B2 (es) |
KR (1) | KR20080020930A (es) |
CN (1) | CN1980673B (es) |
AR (1) | AR050903A1 (es) |
AU (1) | AU2005239847B2 (es) |
CA (1) | CA2564033A1 (es) |
EA (1) | EA010890B1 (es) |
FI (1) | FI20040674A0 (es) |
HK (1) | HK1107000A1 (es) |
NO (1) | NO20065669L (es) |
NZ (3) | NZ579536A (es) |
TW (1) | TWI366463B (es) |
WO (1) | WO2005107757A2 (es) |
ZA (1) | ZA200609304B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20040674A0 (fi) * | 2004-05-12 | 2004-05-12 | Orion Corp | Menetelmä tromboembolisten sairauksien estoon |
US20070010518A1 (en) * | 2005-02-18 | 2007-01-11 | Matti Kivikko | Method for administering levosimendan |
JP2010514778A (ja) * | 2006-12-28 | 2010-05-06 | オリオン コーポレーション | 非経口投与のためのレボシメンダン製剤 |
AR068814A1 (es) * | 2007-08-29 | 2009-12-09 | Orion Corp | Composicion farmaceutica que comprende levosimendan y un inhibidor de la enzima conversina de la angiotensina (ace), y uso |
WO2010097501A2 (en) * | 2009-02-26 | 2010-09-02 | Orion Corporation | A combination treatment |
WO2011027021A1 (en) | 2009-09-01 | 2011-03-10 | Orion Corporation | A method for the treatment of hypertension |
EP2322163A1 (en) * | 2009-11-03 | 2011-05-18 | Pharnext | New therapeutics approaches for treating alzheimer disease |
KR101910153B1 (ko) * | 2016-11-04 | 2018-10-19 | 한국과학기술연구원 | 타우 관련 질환의 예방 또는 치료용 레보시멘단 화합물 |
WO2019216589A1 (ko) * | 2018-05-09 | 2019-11-14 | 한국과학기술연구원 | 타우 관련 질환의 예방 또는 치료용 조성물 |
EP4076398A4 (en) | 2019-12-16 | 2024-01-03 | Tenax Therapeutics, Inc. | LEVOSIMENDAN TO TREAT PULMONARY HYPERTENSION ACCOMPANIED BY HEART FAILURE BY MEANS OF PRESERVED EJECTION FRACTION (PH-HF-PEF) |
CN115518037A (zh) * | 2022-10-14 | 2022-12-27 | 上药东英(江苏)药业有限公司 | 一种安全质量稳定的左西孟旦注射剂组合物及其制备方法 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1468111A (en) * | 1976-01-08 | 1977-03-23 | Pfizer Ltd | Thiophene-sulphonamides |
DE3209159A1 (de) * | 1982-03-13 | 1983-09-15 | Basf Ag, 6700 Ludwigshafen | Neue 6-aryl-4,5-dihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung, diese verbindungen enthaltende therapeutische mittel und deren verwendung |
JPS63141970A (ja) * | 1986-12-04 | 1988-06-14 | Morishita Seiyaku Kk | 4,5−ジヒドロ−6−(4−置換フエニル)−3(2h)−ピリダジノン誘導体 |
GB2251615B (en) | 1991-01-03 | 1995-02-08 | Orion Yhtymae Oy | (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile |
GB2266841A (en) * | 1992-05-06 | 1993-11-17 | Orion Yhtymae Oy | Compounds for use as anti-ischemic medicaments |
US5945432A (en) * | 1995-12-22 | 1999-08-31 | The University Of Vermont And State Agricultural College | Thrombolytic agents and thienopyridine derivatives in acute stroke |
WO1998037888A1 (fr) * | 1997-02-27 | 1998-09-03 | Ajinomoto Co., Inc. | Agent thrombolytique |
FI974578A (fi) * | 1997-12-19 | 1999-06-20 | Orion Yhtymae Oyj | Menetelmä levosimendaanin antamiseksi |
US5905078A (en) | 1998-06-19 | 1999-05-18 | Orion Corporation | Use of a pyridazinone derivative |
FI20001542A (fi) * | 2000-06-29 | 2001-12-30 | Orion Yhtymae Oyj | Menetelmä septisen sokin hoitamiseksi |
FI20011465A0 (fi) | 2001-07-04 | 2001-07-04 | Orion Corp | Pyridatsinonijohdannaisen uusi käyttö |
FI20011464A0 (fi) * | 2001-07-04 | 2001-07-04 | Orion Corp | Yhdistelmäterapia sydämen vajaatoiminnan hoitoon |
EP1430045B1 (en) * | 2001-09-21 | 2006-10-11 | Novartis AG | Pyrane derivatives as both ace- and nep-inhibitors |
FI20020197A0 (fi) * | 2002-02-01 | 2002-02-01 | Orion Corp | Yhdistelmä akuutin myokardiilisen infarktin hoitoon |
FI20030015A0 (fi) * | 2003-01-03 | 2003-01-03 | Orion Corp | Menetelmä munuaisten vajaatoiminnan hoitamiseksi |
EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
FI20040674A0 (fi) * | 2004-05-12 | 2004-05-12 | Orion Corp | Menetelmä tromboembolisten sairauksien estoon |
US20060293395A1 (en) * | 2004-05-28 | 2006-12-28 | Weil Max H | Methods for treating a mammal before, during and after cardiac arrest |
US20070010518A1 (en) * | 2005-02-18 | 2007-01-11 | Matti Kivikko | Method for administering levosimendan |
ES2631879T3 (es) | 2005-11-14 | 2017-09-05 | Boehringer Ingelheim Vetmedica Gmbh | Uso de pimobendano para el tratamiento de la insuficiencia cardíaca asintomática (oculta) |
-
2004
- 2004-05-12 FI FI20040674A patent/FI20040674A0/fi not_active Application Discontinuation
-
2005
- 2005-04-28 TW TW094113669A patent/TWI366463B/zh not_active IP Right Cessation
- 2005-05-11 AR ARP050101922A patent/AR050903A1/es not_active Application Discontinuation
- 2005-05-12 CN CN2005800142213A patent/CN1980673B/zh not_active Expired - Fee Related
- 2005-05-12 NZ NZ579536A patent/NZ579536A/en not_active IP Right Cessation
- 2005-05-12 NZ NZ550814A patent/NZ550814A/en not_active IP Right Cessation
- 2005-05-12 CA CA002564033A patent/CA2564033A1/en not_active Abandoned
- 2005-05-12 AU AU2005239847A patent/AU2005239847B2/en not_active Ceased
- 2005-05-12 NZ NZ579537A patent/NZ579537A/en not_active IP Right Cessation
- 2005-05-12 WO PCT/FI2005/000220 patent/WO2005107757A2/en active Application Filing
- 2005-05-12 EP EP05739367A patent/EP1744752A2/en not_active Withdrawn
- 2005-05-12 JP JP2007512237A patent/JP5074923B2/ja not_active Expired - Fee Related
- 2005-05-12 KR KR1020067023504A patent/KR20080020930A/ko not_active Application Discontinuation
- 2005-05-12 US US11/596,064 patent/US8017609B2/en not_active Expired - Fee Related
- 2005-05-12 EA EA200602096A patent/EA010890B1/ru not_active IP Right Cessation
-
2006
- 2006-11-08 ZA ZA200609304A patent/ZA200609304B/en unknown
- 2006-12-08 NO NO20065669A patent/NO20065669L/no not_active Application Discontinuation
-
2007
- 2007-11-15 HK HK07112472.5A patent/HK1107000A1/xx not_active IP Right Cessation
-
2011
- 2011-08-11 US US13/207,537 patent/US8329693B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2005239847A1 (en) | 2005-11-17 |
JP5074923B2 (ja) | 2012-11-14 |
EA010890B1 (ru) | 2008-12-30 |
ZA200609304B (en) | 2008-01-30 |
US8329693B2 (en) | 2012-12-11 |
CA2564033A1 (en) | 2005-11-17 |
TW200536546A (en) | 2005-11-16 |
US8017609B2 (en) | 2011-09-13 |
US20080039467A1 (en) | 2008-02-14 |
WO2005107757A3 (en) | 2006-01-19 |
WO2005107757A2 (en) | 2005-11-17 |
US20110301166A1 (en) | 2011-12-08 |
EA200602096A1 (ru) | 2007-04-27 |
CN1980673B (zh) | 2011-11-23 |
NO20065669L (no) | 2006-12-08 |
AR050903A1 (es) | 2006-12-06 |
JP2007537209A (ja) | 2007-12-20 |
HK1107000A1 (en) | 2008-03-28 |
CN1980673A (zh) | 2007-06-13 |
NZ550814A (en) | 2009-10-30 |
AU2005239847B2 (en) | 2010-08-26 |
EP1744752A2 (en) | 2007-01-24 |
TWI366463B (en) | 2012-06-21 |
KR20080020930A (ko) | 2008-03-06 |
NZ579536A (en) | 2011-03-31 |
NZ579537A (en) | 2010-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE518856T1 (de) | Herstellverfahren | |
DE602005026757D1 (de) | Tonerherstellungsmethode | |
CY2012027I2 (el) | Μεθοδος βιομηχανικης κατασκευης εμβολιων | |
DK1831605T3 (da) | Fremgangsmåde vedrørende forbrænding | |
NO20084714L (no) | Fremgangsmåte for fremstilling av en biosensor | |
FI20040674A0 (fi) | Menetelmä tromboembolisten sairauksien estoon | |
DK1776099T3 (da) | Fremgangsmåder til forbedring af biotilgængeligheden af en renininhibitor | |
DK1667975T3 (da) | En polymorf form for 3-phenylsulfonyl-8-piperazin-1-yl-quinolin | |
DE602004003115D1 (de) | Tonerherstellungsverfahren | |
NO20040634L (no) | En smiprosess | |
FI20045140A0 (fi) | Kuorintalaite | |
FI20040255A (fi) | Menetelmä pre-eklampsian riskin havaitsemiseksi | |
DK1962960T3 (da) | Fremgangsmåde til mikornisering | |
FR2877088B1 (fr) | Methode de decoincement d'un pneumatique | |
FI20045141A (fi) | Kuorintalaite | |
FI20055166A (fi) | Menetelmä lasimateriaalin valmistamiseksi | |
SE0402399D0 (sv) | New production method | |
FI20040940A0 (fi) | Menetelmä puristettavan kappaleen valmistuksessa | |
FI20041363A0 (fi) | Uusi valmistusmenetelmä | |
FI20075656A0 (fi) | Menetelmä kengän valmistamiseksi | |
NO20044574D0 (no) | En fremgangsmate for a inhibere dannelse av fibrose | |
FI20050909A0 (fi) | Menetelmä levyn valmistamiseksi | |
SE0402428D0 (sv) | New process | |
SE0401623D0 (sv) | New process | |
SE0402706D0 (sv) | Manufacturing Process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |